Internal Medicine, Rheumatology · Babylon, NY
NPI
1710912431
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
500 W Main St, Suite 110
Babylon, NY, 11702
Phone (631) 376-2663
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
193,756 services
Medicare patients, 2024
1,095
Average age 75
Drug cost, 2024
$2.8M
1,839 prescriptions
Company payments, 2025
$112K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barry L Gruber was code J0897 (injection, denosumab, 1 mg), 50,640 times for 526 patients. In total Barry L Gruber billed 193,756 services in 51 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 50,640 | 526 | $20.68 | $1.0M |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 45,360 | 66 | $8.54 | $387K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 36,800 | 28 | $3.62 | $133K |
| J3262 Injection, tocilizumab, 1 mg | Office | 32,820 | 23 | $4.70 | $154K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,125 | 25 | $33.87 | $343K |
| J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2,208 | 34 | $13.79 | $30K |
| 99214 Office E&M - Established | Office | 1,348 | 796 | $109.02 | $147K |
| 96372 Injection Administration | Office | 1,127 | 617 | $12.97 | $15K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 394 | 68 | $0.77 | $303 |
| 77085 Standard X-ray | Office | 312 | 312 | $61.88 | $19K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 244 | 67 | $0.52 | $126 |
| 99213 Office E&M - Established | Office | 237 | 189 | $67.00 | $16K |
| 77080 Standard X-ray | Office | 234 | 234 | $45.03 | $11K |
| J7060 5% dextrose/water (500 ml = 1 unit) | Office | 213 | 62 | $1.42 | $302 |
| 96401 Chemotherapy Administration | Office | 182 | 28 | $67.03 | $12K |
By year: 2022 $4.9M for 394,037 services; 2023 $3.5M for 316,362 services; 2024 $2.7M for 193,756 services.
Medicare prescription drug claims, 2024
In 2024, the drug Barry L Gruber prescribed most often to Medicare patients was Prolia (Denosumab), with 424 prescriptions and refills. In total Barry L Gruber wrote 1,839 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prolia Denosumab | 424 | 2,529 | 253 | $695K |
| Prednisone Generic | 176 | 275 | 68 | $1,727 |
| Alendronate Sodium Generic | 161 | 404 | 62 | $1,255 |
| Duloxetine Hcl Generic | 115 | 265 | 34 | $2,079 |
| Allopurinol Generic | 79 | 224 | 22 | $969 |
| Hydroxychloroquine Sulfate Generic | 70 | 164 | 23 | $2,828 |
| Rinvoq Upadacitinib | 66 | 74 | Under 11 | $453K |
| Celecoxib Generic | 65 | 113 | 21 | $2,028 |
| Methotrexate Methotrexate Sodium | 64 | 177 | 22 | $1,307 |
| Actemra Tocilizumab | 45 | 45 | Under 11 | $177K |
| Humira(Cf) Pen Adalimumab | 33 | 40 | Under 11 | $281K |
| Gabapentin Generic | 33 | 50 | 16 | $375 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 31 | 31 | Under 11 | $73K |
| Raloxifene Hcl Generic | 30 | 90 | Under 11 | $1,071 |
| Diclofenac Sodium Generic | 26 | 30 | Under 11 | $703 |
Brand drugs: - claims; generic drugs: 1,040 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barry L Gruber $112K ($112K in general payments such as food, travel and fees) from 27 companies. The largest payer was Amgen Inc. with $82K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 171 | $82K |
| Abbvie Inc. ABBV | 31 | $14K |
| Kyowa Kirin, Inc. 4151.T | 16 | $7,649 |
| Sobi, Inc SOBI.ST | 5 | $2,824 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $2,627 |
| Janssen Biotech, Inc. JNJ | 29 | $725 |
| UCB, Inc. UCB.BR | 25 | $568 |
| ANI Pharmaceuticals, Inc. ANIP | 14 | $318 |
| Pfizer Inc. PFE | 8 | $296 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $148 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.